Corvus Pharmaceuticals, Inc. (CRVS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Corvus Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -39.78x | -5.24x | -3.13x | -0.96x | -2.33x | -17.51x |
| P/B Ratio | 9.93x | 10.02x | 2.18x | 0.71x | 1.04x | 1.45x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.21x | 1.54x | 4.07x | 4.06x | 7.36x | 3.73x |
| Quick Ratio | 6.21x | 1.54x | 4.07x | 4.06x | 7.36x | 3.73x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.03x | 0.04x | 0.05x | 0.04x | 0.03x |
YoY = year-over-year change. Source: FMP..